← All stocks

MoonLake Immunotherapeutics

MLTX Net selling

CIK 0001821586 #2320 in the set updated 17 Sep 2026

Bought (12 mo)

$98.81K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$129.89M

$11.32M on a plan · $0.00 straight out of an exercise

Sold at will

$118.57M

14 of 32 sales

Net

−$129.80M

−$118.47M against sales at will

By person

7 insiders · 33 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

BVF PARTNERS L P/IL entity

Director

—

$62.96M (3)

−$62.96M

1,039,238

$20.78M

−84.7%

Chen Bihua

Former 10% Owner

—

$46.87M (5)

−$46.87M

1,994,173

$39.88M

−76.5%

Santos da Silva Jorge

Chief Executive Officer

—

$8.73M (7)

−$8.73M

2,774,893

$55.50M

−12.7%

Reich Kristian

Chief Scientific Officer

—

$8.14M (10) scheduled

−$8.14M

2,746,587

$54.93M

−14.5%

Bodenstedt Matthias

Chief Financial Officer

$98.81K (1)

$3.20M (7) scheduled

−$3.10M

1,115,435

$22.31M

+36.8%

Sturge Simon

Director

—

171,980

$3.44M

−49.9%

Moukheibir Catherine

Director

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bodenstedt Matthias

8 Oct 2025

Chief Financial Officer

Buy

10,870

$9.09

$98.81K

Show all 33 transactions →

What was left out

Form 4 filings counted 29

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 18

Sales straight out of an exercise 0

Sales at will 14

Transactions with no price 0

Shares from compensation/vesting 1,406,652

History held since 22 Oct 2020